Life Sciences and Healthcare SPACs
Many companies are wondering if they should consider a SPAC transaction as an alternative to a traditional IPO. In this webinar, panelists discuss considerations around SPAC transactions.
Life Sciences and Healthcare SPACs: An Alternate Pathway to Going Public
September 2020 – Special purpose acquisition company (SPAC) IPOs have raised a record amount of capital this year, and an increasing number of companies are considering SPAC transactions as an alternative to a traditional IPO. In this webinar, experts discussed considerations around SPAC transactions vs. traditional IPOs.
- The SPAC business combination process
- SPAC sponsors’ increasing focus on life sciences and healthcare
- Considerations associated with going public through a SPAC business combination compared to a traditional IPO